Empresa Sucampo Pharmaceuticals, Inc.
Acciones
US8649091068
Biotecnología e investigación médica
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 46 636 924 | 45 389 949 ( 97,33 %) | 227 266 ( 0,4873 %) | 97,33 % |
Información de la empresa
Sucampo Pharmaceuticals, Inc.
805 King Farm Boulevard Suite 550
20850, Rockville
+301-961-3400
http://sucampo.com![Dirección Sucampo Pharmaceuticals, Inc.](https://cdn.zonebourse.com/static/address/57306.png)
Empresas del grupo
Nombre | Categoría y sector |
---|---|
Sucampo Pharma LLC
![]() Sucampo Pharma LLC Miscellaneous Commercial ServicesCommercial Services Sucampo Pharma LLC engages in the pharmaceutical product development. It develops the naturally occurring compound prostones, including lubiprostone under the brand Amitiza, which is used for the treatment of chronic constipation, chronic idiopathic constipation (CIC) in adults, and irritable bowel syndrome with constipation (IBS-C). The company is headquartered in Osaka, Japan. |
Miscellaneous Commercial Services
|
Sector
Varia. 1 de ene. | Capi. | |
---|---|---|
+16,50 % | 121 mil M | |
+17,85 % | 110 mil M | |
+17,12 % | 25,98 mil M | |
-24,30 % | 19,27 mil M | |
-18,56 % | 15,99 mil M | |
-18,02 % | 15,66 mil M | |
-47,75 % | 14,5 mil M | |
+57,51 % | 14,47 mil M | |
+5,27 % | 13,91 mil M |